anti inflammatory effects of glp 1 Antiinflammatory actions glucagon-like peptide-1–based therapies beyond metabolic benefits Long-Term Effects Of GLP-1 Medications:

Supplemental Material Supplemental material, sj-docx-1-eso-10.1177_23969873241234238 for Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis by Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra, Diana Aguiar de Sousa, Mira Katan, Lina Palaiodimou, Aristeidis H Katsanos, Ioanna Koutroulou, Vaia Lambadiari, Robin Lemmens, Sotirios Giannopoulos, Andrei V Alexandrov, Gerasimos Siasos and Georgios Tsivgoulis in European Stroke Journal Acknowledgments None Footnotes The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article

[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Nauck M., Stockmann F., Ebert R., Creutzfeldt W

Part 1 of 2 covers the mechanism and the U/kg trend, the portal-peripheral mismatch, and the Ominous Octet framework

doi:10.2174/1389450043345245 184

T2DM Type 2 Diabetes Mellitus